Literature DB >> 11081205

Endocrine/paracrine control of pituitary cell proliferation and its involvement in pituitary tumorigenesis.

M Pawlikowski1.   

Abstract

The paper concisely reviews the data on the humoral factors which regulate the anterior pituitary cell proliferation in endocrine and/or paracrine manner. Their relevance for pituitary tumorigenesis is also discussed. The role of estrogens, growth factors, neuropeptides, dopamine, interleukins and angiotensins is presented.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 11081205     DOI: 10.1023/a:1009998207652

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  69 in total

1.  A renin-like activity in pineal gland and hypophysis.

Authors:  I Haulica; D D Branisteanu; V Rosca; A Stratone; V Berbeleu; G Balan; L Ionescu
Journal:  Endocrinology       Date:  1975-02       Impact factor: 4.736

2.  Effects of oestrogen and bromocryptine on in vivo secretion and mitosis in prolactin cells.

Authors:  H M Lloyd; J D Meares; J Jacobi
Journal:  Nature       Date:  1975-06-05       Impact factor: 49.962

3.  Characterization of Interleukin-2 (IL-2) receptor expression and action of IL-2 and IL-6 on normal anterior pituitary cell growth.

Authors:  E Arzt; J Sauer; R Buric; J Stalla; U Renner; G K Stalla
Journal:  Endocrine       Date:  1995-02       Impact factor: 3.633

4.  Overexpression of the growth-hormone-releasing hormone gene in acromegaly-associated pituitary tumors. An event associated with neoplastic progression and aggressive behavior.

Authors:  K Thapar; K Kovacs; L Stefaneanu; B Scheithauer; D W Killinger; R V Lioyd; H S Smyth; A Barr; M O Thorner; B Gaylinn; E R Laws
Journal:  Am J Pathol       Date:  1997-09       Impact factor: 4.307

5.  Cellular receptors for sex steroids in human pituitary adenomas.

Authors:  M L Jaffrain-Rea; E Petrangeli; F Ortolani; B Fraioli; A Lise; V Esposito; L G Spagnoli; G Tamburrano; L Frati; A Gulino
Journal:  J Endocrinol       Date:  1996-11       Impact factor: 4.286

6.  Effect of angiotensin II on the proliferation of mammotrophs from the adult rat anterior pituitary in culture.

Authors:  T Shinkai; H Ooka
Journal:  Peptides       Date:  1995       Impact factor: 3.750

7.  Direct arterial vascularization of estrogen-induced prolactin-secreting anterior pituitary tumors.

Authors:  K A Elias; R I Weiner
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

8.  Proliferation Markers and EGF in ACTH-Secreting Adenomas and Carcinomas of the Pituitary.

Authors:  Dorothee Lubke; Wolfgang Saeger; Dieter K. Ludecke
Journal:  Endocr Pathol       Date:  1995       Impact factor: 3.943

9.  Expression of epidermal growth factor (EGF), its receptor, and related oncoprotein (erbB-2) in human pituitary tumors and response to EGF in vitro.

Authors:  S S Chaidarun; M C Eggo; M C Sheppard; P M Stewart
Journal:  Endocrinology       Date:  1994-11       Impact factor: 4.736

10.  Tissue specific hormonal regulation of the rat angiotensinogen gene expression.

Authors:  S P Kunapuli; C R Benedict; A Kumar
Journal:  Arch Biochem Biophys       Date:  1987-05-01       Impact factor: 4.013

View more
  2 in total

1.  Locally produced estrogen through aromatization might enhance tissue expression of pituitary tumor transforming gene and fibroblast growth factor 2 in growth hormone-secreting adenomas.

Authors:  Hande Mefkure Ozkaya; Nil Comunoglu; Fatma Ela Keskin; Buge Oz; Ozlem Asmaz Haliloglu; Necmettin Tanriover; Nurperi Gazioglu; Pinar Kadioglu
Journal:  Endocrine       Date:  2015-11-17       Impact factor: 3.633

Review 2.  Relation among Aromatase P450 and Tumoral Growth in Human Prolactinomas.

Authors:  María José García-Barrado; Enrique J Blanco; María Carmen Iglesias-Osma; Marta Carretero-Hernández; Leonardo Catalano-Iniesta; Virginia Sanchez-Robledo; Manuel Carretero; Julio Joaquín Herrero; Sixto Carrero; José Carretero
Journal:  Int J Mol Sci       Date:  2017-11-01       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.